Feature

White House pushes transparency in drug price plan


 


“It’s time to end the global freeloading once and for all,” President Trump said. “I have directed U.S. Trade Representative Bob Lighthizer to make fixing this injustice a top priority with every trading partner.”

One proposal President Trump campaigned on – giving the federal government the power to directly negotiate for drug prices – was not included in the plan.

“I am very disappointed that he has apparently dropped his support for allowing Medicare to negotiate the price of prescription drugs,” Sen. Maggie Hassan (D-N.H.) said in a statement.

Also absent from the plan: a direct negotiation tactic for Part B drugs supported by Mr. Azar during his confirmation hearings.

Pages

Recommended Reading

MDedge Daily News: How to handle opioid constipation
MDedge Rheumatology
MDedge Daily News: Where the latest HCV drug combos fit in
MDedge Rheumatology
HHS says no to lifetime limits on Medicaid
MDedge Rheumatology
Uninsured rate on the rise
MDedge Rheumatology
MDedge Daily News: Research reveals surprises in mental health and gun violence
MDedge Rheumatology
Zika topped Lyme in 2016
MDedge Rheumatology
MDedge Daily News: Deep concern surrounding Title X changes
MDedge Rheumatology
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Rheumatology
White House targets CHIP, CMMI for budget cuts
MDedge Rheumatology
New Medicare cards
MDedge Rheumatology